Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment

Clinical trial NCT00171795 · COMPLETED

Trial details

NCT number: NCT00171795
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Traumatic Brain Injury

Start date: 2002-11-01
Primary completion: 2005-05-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.